Expanded evidence that the 31-gene expression profile test provides clinical utility for melanoma management in a multicenter study.

Saved in:
Bibliographic Details
Title: Expanded evidence that the 31-gene expression profile test provides clinical utility for melanoma management in a multicenter study.
Authors: Dillon LD; Larry D. Dillon Surgical Oncology and General Surgery, Colorado Springs, CO, USA., McPhee M; Breast Cancer Program, Advent Health Cancer Institute, Orlando, FL, USA., Davidson RS; Department of Surgical Oncology, Morton Plant Mease Healthcare, FL, USA., Quick AP; Castle Biosciences, Inc, Friendswood, TX, USA., Martin B; Castle Biosciences, Inc, Friendswood, TX, USA., Covington KR; Castle Biosciences, Inc, Friendswood, TX, USA., Zolochevska O; Castle Biosciences, Inc, Friendswood, TX, USA., Cook RW; Castle Biosciences, Inc, Friendswood, TX, USA., Vetto JT; Department of Neurology, Surgical Oncology, Oregon Health & Science University, Portland, OR, USA., Jarell AD; Department of Dermatology, Northeast Dermatology Associates, P.C., Portsmouth, NH, USA., Fleming MD; Department of Surgical Oncology, The University of Tennessee Health Science Center, Memphis, TN, USA.
Source: Current medical research and opinion [Curr Med Res Opin] 2022 Aug; Vol. 38 (8), pp. 1267-1274. Date of Electronic Publication: 2022 Feb 15.
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 0351014 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-4877 (Electronic) Linking ISSN: 03007995 NLM ISO Abbreviation: Curr Med Res Opin Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1473-4877
DOI:10.1080/03007995.2022.2033560